Watchlist Price Alert

Gain Therapeutics Inc. (GANX)

NASDAQ: GANX · Real-Time Price · USD

2.06

-0.12 (-5.50%)

At close: May 02, 2025, 3:59 PM

2.03

-1.22%

After-hours: May 02, 2025, 05:24 PM EDT

Gain Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-20.41M	-22.27M	-17.59M	-13.89M	-3.58M	-2.19M	-1.11M
Depreciation & Amortization	84.07K	83.58K	64.17K	15.48K	9.59K	2.57K	741.00
Stock-Based Compensation	2.39M	3.26M	1.53M	839.37K	81.64K	n/a	n/a
Other Working Capital	-1.36M	1.09M	448.15K	34.7K	-129.31K	218.99K	201.55K
Other Non-Cash Items	143.52K	-383.19K	-206.86K	-34.13K	8.71K	10.1K	41.05K
Deferred Income Tax	n/a	n/a	n/a	1.09M	n/a	n/a	n/a
Change in Working Capital	-1.08M	442.23K	1.51M	-385.11K	237.5K	312.26K	319.23K
Operating Cash Flow	-18.87M	-18.87M	-14.69M	-12.37M	-3.24M	-1.87M	-744.51K
Capital Expenditures	-22.49K	-15.36K	-118.95K	-94.21K	-20.83K	-13.72K	-7.99K
Cash Acquisitions	n/a	n/a	14.66M	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-1.96M	-17.74M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	5M	12.19M	3.08M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-14.66M	n/a	n/a	n/a	7.99K
Investing Cash Flow	4.98M	10.22M	-14.77M	-94.21K	-20.83K	-13.72K	-7.99K
Debt Repayment	-90.88K	-89.07K	-78.77K	-21.95K	738.28K	n/a	983.78K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-109.36K	n/a	n/a	-841.27K	-470.75K	n/a	n/a
Financial Cash Flow	13.01M	12.64M	-78.77K	41.77M	10.49M	1.75M	983.78K
Net Cash Flow	-1.41M	4.49M	-29.57M	29.41M	7.19M	-97.19K	237.88K
Free Cash Flow	-18.9M	-18.88M	-14.81M	-12.46M	-3.26M	-1.88M	-752.5K